Equities

Tokens.com Corp

Tokens.com Corp

Actions
  • Price (CAD)0.145
  • Today's Change0.00 / 0.00%
  • Shares traded258.01k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of May 16 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Tokens.com Corp. is a technology company focused on building humanoid robotics and companionship based artificial intelligence (AI). The Company also owns an inventory of cryptocurrencies and a collection of crypto-related domain names. The Company, through Simulacra Corporation, owns and operates three subsidiaries, Realbotix, Anthropomorphic Figure Dynamics (AFD), and Abyss Creations, which are focused on the integration of AI and humanoid robots that improve the human experience through connection, learning and play. Realbotix builds customized robots that are AI-enabled. AFD is a division that caters to government and healthcare projects that require realistic humanoids. Abyss Creations builds companionship-based humanoid figures that have the ability to be integrated with AI features. The Company’s assets provide exposure to AI, blockchain, robotics and Web3.

  • Revenue in CAD (TTM)1.08m
  • Net income in CAD-5.44m
  • Incorporated2009
  • Employees4.00
  • Location
    Tokens.com Corp3400 One First Canadian Place100 King Street WestTORONTO M5H 0B4CanadaCAN
  • Phone+1 (647) 578-7490
  • Fax+1 (416) 848-9407
  • Websitehttps://www.tokens.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Antibe Therapeutics Inc0.00-18.24m15.63m11.00--0.599-----0.3466-0.35250.000.49250.00----0.00-28.04-41.95-29.31-46.17-------349.76----0.00------23.60---29.21--
Hempalta Corp0.00-3.11k16.13m----1.52-----0.00007-0.000070.000.11190.00-------0.1168---0.1181--------------0.00------113.13------
Resverlogix Corp0.00-22.78m16.46m18.00---------0.0845-0.08450.00-0.37210.00----0.00-228.80--------------0.0081-0.5027---------363.74------
Tokens.com Corp1.08m-5.44m18.74m4.00--0.9166--17.41-0.0483-0.04830.00920.16910.043--7.17---22.94---26.94--90.76---533.94------0.0083--------------
Kane Biotech Inc148.98k-4.56m19.76m--------132.66-0.0359-0.03960.0012-0.08010.02640.07790.9169---80.74-77.89----73.4843.27-3,062.39-241.850.3188-2.7810.99---94.42-20.26-17.29---19.41--
Ceapro Inc9.63m-4.71m21.13m12.00--0.7589--2.19-0.0602-0.06020.12310.35580.27851.256.45---13.622.46-14.422.5941.0752.27-48.895.135.49-39.490.07470.00-48.87-3.64-207.09---3.60--
Avant Brands Inc27.39m-7.95m21.41m180.00--0.4279--0.7818-0.0295-0.02950.10430.17530.34410.97125.02152,172.20-9.95-15.93-12.87-19.5039.7037.78-28.90-63.750.7269-1.250.262--30.75240.2632.78---23.24--
Data as of May 16 2024. Currency figures normalised to Tokens.com Corp's reporting currency: Canadian Dollar CAD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.